314 related articles for article (PubMed ID: 25304686)
1. Clinically relevant microRNAs in ovarian cancer.
Zhang S; Lu Z; Unruh AK; Ivan C; Baggerly KA; Calin GA; Li Z; Bast RC; Le XF
Mol Cancer Res; 2015 Mar; 13(3):393-401. PubMed ID: 25304686
[TBL] [Abstract][Full Text] [Related]
2. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
Creighton CJ; Hernandez-Herrera A; Jacobsen A; Levine DA; Mankoo P; Schultz N; Du Y; Zhang Y; Larsson E; Sheridan R; Xiao W; Spellman PT; Getz G; Wheeler DA; Perou CM; Gibbs RA; Sander C; Hayes DN; Gunaratne PH;
PLoS One; 2012; 7(3):e34546. PubMed ID: 22479643
[TBL] [Abstract][Full Text] [Related]
3. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Zhang L; Volinia S; Bonome T; Calin GA; Greshock J; Yang N; Liu CG; Giannakakis A; Alexiou P; Hasegawa K; Johnstone CN; Megraw MS; Adams S; Lassus H; Huang J; Kaur S; Liang S; Sethupathy P; Leminen A; Simossis VA; Sandaltzopoulos R; Naomoto Y; Katsaros D; Gimotty PA; DeMichele A; Huang Q; Bützow R; Rustgi AK; Weber BL; Birrer MJ; Hatzigeorgiou AG; Croce CM; Coukos G
Proc Natl Acad Sci U S A; 2008 May; 105(19):7004-9. PubMed ID: 18458333
[TBL] [Abstract][Full Text] [Related]
4. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.
Woo HH; László CF; Greco S; Chambers SK
Mol Cancer; 2012 Aug; 11():58. PubMed ID: 22909061
[TBL] [Abstract][Full Text] [Related]
5. An integrated network of microRNA and gene expression in ovarian cancer.
Quitadamo A; Tian L; Hall B; Shi X
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.
Kan CW; Howell VM; Hahn MA; Marsh DJ
Genes Chromosomes Cancer; 2015 Jan; 54(1):1-19. PubMed ID: 25280227
[TBL] [Abstract][Full Text] [Related]
7. miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
Hua Y; Larsen N; Kalyana-Sundaram S; Kjems J; Chinnaiyan AM; Peter ME
BMC Genomics; 2013 Mar; 14():179. PubMed ID: 23497354
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
Nakano H; Yamada Y; Miyazawa T; Yoshida T
Int J Oncol; 2013 Jun; 42(6):1875-82. PubMed ID: 23588298
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
10. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
12. Herpes virus microRNA expression and significance in serous ovarian cancer.
Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
[TBL] [Abstract][Full Text] [Related]
13. The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated.
Shahab SW; Matyunina LV; Hill CG; Wang L; Mezencev R; Walker LD; McDonald JF
BMC Med Genomics; 2012 Aug; 5():33. PubMed ID: 22853714
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
16. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
[TBL] [Abstract][Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.
Creighton CJ; Fountain MD; Yu Z; Nagaraja AK; Zhu H; Khan M; Olokpa E; Zariff A; Gunaratne PH; Matzuk MM; Anderson ML
Cancer Res; 2010 Mar; 70(5):1906-15. PubMed ID: 20179198
[TBL] [Abstract][Full Text] [Related]
19. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA signatures in human ovarian cancer.
Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM
Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
